Rare diseases
Investigational molecules
Locations
225 Northeast Mizner Boulevard Suite 640, 33432-4080, United States
Clinical research is centered on early Alzheimer’s disease, with attention to patients identified by biomarkers of inflammation. The sponsor’s work in this area reflects a focus on disease stages where cognitive decline is emerging and inflammatory activity is clinically relevant.
Research activity in this field aligns with therapeutic interest in interventions aimed at preserving cognitive performance in the setting of early neurodegeneration.
Inmune Bio Inc. runs clinical trials in conditions such as Dementia of the Alzheimer's type uncomplicated, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
